Full-Format Antibody Humanization

NBLST has developed proprietary gene expression technology that precisely restricts the integrated gene copy number per cell to one and tightly regulates the expression level of displayed targets within an appropriate range, preventing compromised screening accuracy caused by overexpression.

Phage display delivers large libraries and short cycles for antibody screening. Our exclusive plasmid system supports both phage library construction and mammalian expression to boost druggability. NBLST NabLib® offers efficient antibody discovery & engineering via dual-functional phage display to accelerate antibody therapeutics R&D.